Volume Contribution of D5W in Clinical Settings

Physiologic Basis

D5W is isotonic when infused but becomes hypotonic once the dextrose is metabolized by cells, providing no renal osmotic load once dextrose is cleared 1
The solution contains no sodium or other electrolytes, and after dextrose metabolism, the remaining free water distributes across intracellular and extracellular compartments according to normal body water distribution 2

Approximately 80-100 mL per liter of D5W infused expands plasma volume, as most water shifts intracellularly, making D5W inappropriate for resuscitation or volume replacement in hypovolemic states 2
The American College of Physicians and other medical societies imply that isotonic crystalloids, which expand plasma volume by approximately 300 mL per liter administered, are more suitable for volume replacement 2

Isotonic saline has a tonicity that exceeds typical urine osmolality in conditions like nephrogenic diabetes insipidus, risking serious hypernatremia in patients unable to concentrate urine 1
D5W delivers zero renal osmotic load after dextrose metabolism, making it the preferred fluid for hypernatremic states and conditions with impaired urinary concentration, as recommended by the National Kidney Foundation 1

The European Society of Intensive Care Medicine and other critical care societies suggest that D5W is the fluid of choice for hypernatremic dehydration, particularly in nephrogenic diabetes insipidus, with initial infusion rates of 100 mL/hour in adults providing slow, controlled correction of plasma osmolality 1
In patients with cardiac or renal compromise, the American Heart Association and the National Kidney Foundation recommend limiting D5W infusion rates to ≤100 mL/hour and monitoring closely for fluid overload despite minimal plasma expansion 3, 4

When D5W serves as a vehicle for medication infusions, the volume contribution remains 1:1, but infusion rates are dictated by medication dosing rather than volume needs, according to the American Society of Health-System Pharmacists 5, 6
Blood glucose monitoring is essential regardless of infusion rate when D5W is used as a drug vehicle, as stated by the Endocrine Society 7